cDNA array analysis of the differential expression change in virulence-related genes during the development of resistance in Candida albicans

Acta Biochimica et Biophysica Sinica

Volumn 37, Issue 7, 2005, Pages 463-472

  Xu, Zheng ^a   Cao, Yong Bing ^a   Zhang, Jun Dong ^a   Cao, Ying Ying ^a   Gao, Ping Hui ^a   Wang, De Jun ^a   Fu, Xu Ping ^a   Ying, Kang ^b   Chen, Wan Sheng ^a   Jiang, Yuan Ying ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Candida albicans; cDNA array; Resistance; Virulence

Indexed keywords

CANDIDA ALBICANS; FUNGI;

FLUCONAZOLE;

ANTIBIOTIC RESISTANCE; ARTICLE; CANDIDA ALBICANS; DNA MICROARRAY; DRUG EFFECT; FUNGAL GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METHODOLOGY; PATHOGENICITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRULENCE;

CANDIDA ALBICANS; DRUG RESISTANCE, FUNGAL; FLUCONAZOLE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, FUNGAL; GENES, FUNGAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VIRULENCE;

EID: 24944544469     PISSN: 16729145     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1745-7270.2005.00063.x     Document Type: Article

References (42)

1. Jones T, Federspiel NA, Chibana H, Dungan J, Kalman S, Magee BB, Newport G et al. The diploid genome sequence of Candida albicans. Proc Natl Acad Sci USA 2004, 101: 7329-7334
2. Morschhauser J. The genetic basis of fluconazole resistance development in Candida albicans. Biochim Biophys Acta 2002, 1587: 240-248
3. Ruhnke M, Eigler A, Tennagen I, Geiseler B, Engelmann E, Trautmann M. Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. J Clin Microbiol 1994, 32: 2092-2098
4. White TC, Holleman S, Dy F, Mirels LF, Stevens DA. Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob Agents Chemother 2002, 46: 1704-1713
5. Rex JH, Rinaldi MG, Pfaller MA. Resistance of Candida species to fluconazole. Antimicrob Agents Chemother 1995, 39: 1-8
6. Sanglard D. Clinical relevance of mechanisms of antifungal drug resistance in yeasts. Enferm Infecc Microbiol Clin 2002, 20: 462-469; quiz 470, 479
7. Naglik JR, Challacombe SJ, Hube B. Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev 2003, 67: 400-428
8. Yang YL. Virulence factors of Candida species. J Microbiol Immunol Infect 2003, 36: 223-228
9. Tavanti A, Pardini G, Campa D, Davini P, Lupetti A, Senesi S. Differential expression of secretory aspartyl proteinase genes (SAP1-10) in oral Candida albicans isolates with distinct karyotypes. J Clin Microbiol 2004, 42: 4726-4734
10. Zhao X, Oh SH, Cheng G, Green CB, Nuessen JA, Yeater K, Leng RP et al. ALS3 and ALS8 represent a single locus that encodes a Candida albicans adhesin: Functional comparisons between Als3p and Als1p. Microbiology 2004, 150: 2415-2428
11. Alberti-Segui C, Morales AJ, Xing H, Kessler MM, Willins DA, Weinstock KG, Cottarel G et al. Identification of potential cell-surface proteins in Candida albicans and investigation of the role of a putative cell-surface glycosidase in adhesion and virulence. Yeast 2004, 21: 285-302
12. Martinez M, Lopez-Ribot JL, Kirkpatrick WR, Bachmann SP, Perea S, Ruesga MT, Patterson TF. Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis. J Antimicrob Chemother 2002, 49: 515-524
13. Perea S, Lopez-Ribot JL, Kirkpatrick WR, McAtee RK, Santillan RA, Martinez M, Calabrese D et al. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Antimicrob Agents Chemother 2001, 45: 2676-2684
14. Ollert MW, Wende C, Gorlich M, McMullan-Vogel CG, Borg-von Zepelin M, Vogel CW, Korting HC. Increased expression of Candida albicans secretory proteinase, a putative virulence factor, in isolates from human immunodeficiency virus-positive patients. J Clin Microbiol 1995, 33: 2543-2549
15. Ghannoum MA. Candida albicans antifungalzole-resistant resistant strains: Studies on adherence and other pathogenicity-related characteristics. Mycoses 1992, 35: 131-139
16. Becker JM, Henry LK, Jiang W, Koltin Y. Reduced virulence of Candida albicans mutants affected in multidrug resistance. Infect Immun 1995, 63: 4515-4518.
17. Fonzi WA, Irwin MY. Isogenic strain construction and gene mapping in Candida albicans. Genetics 1993, 134: 717-728
18. National committee for clinical laboratory standards, reference method for broth dilution antifungal susceptibility testing of yeasts: Approved standard. NCCLS document M27-A. NCCLS, Villanova, PA, USA 1997
19. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162: 156-159
20. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. Gapped BLAST and Psi-BLAST: A new generation of protein database search programs. Nucleic Acids Res 1997, 25: 3389-3402
21. Marra MA, Kucaba TA, Hillier LW, Waterston RH. High throughput plasmid DNA purification for 3 cents per sample. Nucleic Acids Res 1999, 27: 37
22. Li Y, Li Y, Tang R, Xu H, Qiu M, Chen Q, Chen J et al. Discovery and analysis of hepatocellular carcinoma genes using cDNA microarrays. J Cancer Res Clin Oncol 2002, 128: 369-379
23. Ye RW, Wang T, Bedzyk L, Croker KM. Applications of DNA microarrays in microbial systems. J Microbiol Methods 2001, 47: 257-272
24. Leng P, Lee PR, Wu H, Brown AJ. Efg1, a morphogenetic regulator in Candida albicans, is a sequence-specific DNA binding protein. J Bacteriol 2001, 183: 4090-4093
25. Stoldt VR, Sonneborn A, Leuker CE, Ernst JF. Efg1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi. EMBO J 1997, 16: 1982-1991
26. Ramage G, VandeWalle K, Lopez-Ribot JL, Wickes BL. The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans. FEMS Microbiol Lett 2002, 214: 95-100
27. Ramage G, Saville SP, Wickes BL, Lopez-Ribot JL. Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl Environ Microbiol 2002, 68: 5459-5463
28. Staab JF, Bahn YS, Tai CH, Cook PF, Sundstrom P. Expression of transglutaminase substrate activity on Candida albicans germ tubes through a coiled, disulfide-bonded N-terminal domain of Hwp1 requires C-terminal glycosylphosphatidylinositol modification. J Biol Chem 2004, 279: 40737-40747
29. Sohn K, Urban C, Brunner H, Rupp S. EFG1 is a major regulator of cell wall dynamics in Candida albicans as revealed by DNA microarrays. Mol Microbiol 2003, 47: 89-102
30. Lane S, Zhou S, Pan T, Dai Q, Liu H. The basic helix-loop-helix transcription factor Cph2 regulates hyphal development in Candida albicans partly via TEC1. Mol Cell Biol 2001, 21: 6418-6428
31. Liu H. Transcriptional control of dimorphism in Candida albicans. Curr Opin Microbiol 2001, 4: 728-735
32. Bassilana M, Blyth J, Arkowitz RA. Cdc24, the GDP-GTP exchange factor for Cdc42, is required for invasive hyphal growth of Candida albicans. Eukaryot Cell 2003, 2: 9-18
33. VandenBerg AL, Ibrahim AS, Edwards JE Jr, Toenjes KA, Johnson DI. Cdc42p GTPase regulates the budded-to-hyphal-form transition and expression of hypha-specific transcripts in Candida albicans. Eukaryot Cell 2004, 3: 724-734
34. Klotz SA, Gaur NK, Lake DF, Chan V, Rauceo J, Lipke PN. Degenerate peptide recognition by Candida albicans adhesins Als5p and Als1p. Infect Immun 2004, 72: 2029-2034
35. Leng P, Sudbery PE, Brown AJ. Rad6p represses yeast-hypha morphogenesis in the human fungal pathogen Candida albicans. Mol Microbiol 2000, 35: 1264-1275
36. Roig P, Gozalbo D. Depletion of polyubiquitin encoded by the UBI4 gene confers pleiotropic phenotype to Candida albicans cells. Fungal Genet Biol 2003, 39: 70-81
37. Barker KS, Crisp S, Wiederhold N, Lewis RE, Bareither B, Eckstein J, Barbuch R et al. Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans. J Antimicrob Chemother 2004, 54: 376-385
38. Rogers PD, Barker KS. Genome-wide expression profile analysis reveals coordinately regulated genes associated with stepwise acquisition of azole resistance in Candida albicans clinical isolates. Antimicrob Agents Chemother 2003, 47: 1220-1227
39. Warenda AJ, Konopka JB. Septin function in Candida albicans morphogenesis. Mol Biol Cell 2002, 13: 2732-2746
40. Warenda AJ, Kauffman S, Sherrill TP, Becker JM, Konopka JB. Candida albicans septin mutants are defective for invasive growth and virulence. Infect Immun 2003, 71: 4045-4051
41. Marr KA, Lyons CN, Rustad TR, Bowden RA, White TC. Rapid, transient fluconazole resistance in Candida albicans is associated with increased mRNA levels of CDR. Antimicrob Agents Chemother 1998, 42: 2584-2589
42. Marr KA, Lyons CN, Ha K, Rustad TR, White TC. Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans. Antimicrob Agents Chemother 2001, 45: 52-59